Practitioners nationwide are striving to do what’s best for children’s health, while staying supportive in the face of mistrust and confusion.

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be granted market authorization in the European Union, marking the first time ...

Moderna seeks to return to growth Its share price has lost 90% from pandemic peaks Anti-vaccine health secretary has disrupted US vaccine policy Feb 27 (Reuters) - Europe's medicines regulator ...

The European Medicines Agency (EMA) has recommended granting marketing authorization to the combined influenza and COVID-19 messenger RNA (mRNA) vaccine, mCombriax (Moderna), for people aged 50 years ...

For the past week, about 50 flu scientists from around the world were crammed into a conference room at a Hilton hotel in Istanbul, Turkey. Their goal was to design a flu shot that will confer the ...

Flu cases at Deaconess jumped 53% in one week and RSV rose 13%, officials reported Tuesday. Indiana has recorded 130 flu deaths this season, including two children. A new flu variant not in this ...

It didn't take long for the topic of vaccines to come up in surgeon general nominee Dr. Casey Means' confirmation hearing. During the Feb. 25 hearing, members of the Senate Committee on Health, ...

(The Hill) – President Trump’s nominee for surgeon general, Casey Means, on Wednesday said she won’t broadly encourage parents to vaccinate their children against measles, the flu or whooping cough, ...

The company revised its plan to seek full approval for middle-aged adults and accelerated approval for senior. HealthDay News — In a sudden reversal, the U.S. Food and Drug Administration (FDA) has ...

Neil Mabbott receives research funding from the UK Biotechnology and Biological Sciences Research Council, the Roslin Foundation, the Creutzfeldt-Jakob Disease Foundation, and Zoetis. Vaccines have ...

Under the newly accepted application, Moderna is seeking full approval for adults age 50 to 64 years, but for those age 65 years and older, it is seeking "accelerated approval." HealthDay News — In a ...